Topic 11B Flashcards

1
Q

Two Main Goals of Cardioplegia

A
  1. Prevent myocardial ischemic damage (induction/maintenance)
  2. Prevent/minimize injury (reperfusion)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

limit detrimental changes such as (7)

A
  1. rapid cellular conversion from aerobic (O2) to anaerobic metabolism (no O2)
  2. high-energy phosphate (e.g. ATP) depletion
  3. intracellular acidosis
  4. calcium influx
  5. cell membrane disruption
  6. Intracellular Ca++ accumulation
  7. Cellular edema (inability to consume oxygen)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cardioplegia Setups include:

A

crystalloid
blood
MPS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Crystalloid=

A

Single pass system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Blood cardioplegia setup=

A
  1. Fixed ratio (Bridged or Non-bridged)

2. Variable/controlled ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MPS=

A

microcardioplegia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

3 Phases of Cardioplegia include

A

Induction of arrest
Maintenance of arrest
Reperfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cold Induction Solutions (Crystalloid and Blood)= (4)

A
  1. ECF cardioplegia solution
  2. Potassium depolarization arrest
  3. Depolarizes the cardiac myocyte with hyperkalemia
  4. Ca++ ATPase and Na+/K+ATPase still operative and need energy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pure Crystalloid Cardioplegia Induction:

Advantages (4)

A

History of use
Ease
Cheap
Low viscosity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pure Crystalloid Cardioplegia Induction:

Disadvantages (6)

A
Cellular edema
Low O2 capacity
Left shift oxy-Hgb curve
Activates platelets, leukocytes, and complement
Impaired membrane stabilization
Hemodilution
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
Generic Crystalloid Solutions:
Lactated Ringer’s 1000 mL 
KCL=
MgCl=
Mannitol=
NaHCO2=
A

KCL 20 mEq
MgCl 32 mEq
Mannitol 12.5 g
NaHCO2 6.5 mEq

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Lactated Ringer’s 1000 mL: What do you add prior to use?

A

Procaine 10% 2.7 mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
Generic Crystalloid Solutions:
Normosol 1000 mL 
NaHCO2=
KCL=
Mannitol=
A

NaHCO2 35 mEq
KCL 35 mEq
Mannitol 25% 12.5 g

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Normosol 1000 mL: What do you give prior to use? (3)

A

Lidocaine 75 mg
Ntg 500 mcg
Albumin 25% 12.5 g

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cold Blood Cardioplegia Induction

Advantages (4)

A

O2 carrying capacity
Reduced hemodilution
Buffering/oncotic effects
O2 radical scavengers present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cold Blood Cardioplegia Induction

Disadvantages (3)

A

Sludging
Oxy-Hgb curve disruption
Possible red cell damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Warm Blood Cardioplegia Induction

Advantages (3)

A

Improved aerobic metabolism
Improved LV function
Improves compromised hearts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Warm Blood Cardioplegia Induction

Disadvantages

A

Expensive due to additives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Low Potassium Maintenance= (3)

A
  • Usually every 15 to 20 minutes
  • Cold blood cardioplegia or crystalloid
  • Restores arrest post wash-out
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Preparation for Reperfusion= (6)

A
Substrate-enhanced warm cardioplegia
Limit calcium
Limit PO2
Controlled reperfusion 
De-air adequately
Avoid ventricular distension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Know the SV per tubing size

A

look at lab notes from last quarter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Controlled reperfusion=

A

The endothelium is damaged during ischemia–damage can increase through unregulated reperfusion
•Upon XC Removal: MAP → 40 mmHg for 1-2 minutes then MAP→ 70 mmHg after 2 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Hot Shot=

A
  • Just prior to removal of the aortic cross clamp

- In addition to cross clamp drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Cross clamp drugs (4)

A
Aspartate Glutamate
Tham
Dextrose
CPD
--Due to cost: warm blood may be substituted
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Custodial Cardioplegia =(HTK)
Histidine Tryptophan Ketoglutarate
26
Custodial Cardioplegia (HTK): Intracellular cardioplegia solution (4)
Low sodium concentration Histidine Tryptophan Mannitol
27
Benefits of HTK Cardioplegia: Initial use
organ protection
28
Benefits of HTK Cardioplegia: Now used in cardiac surgery because (3)
Longer safe time of ischemia During valve surgery Minimally invasive procedures
29
Del Nido Solution (4:1)=
Plasmalyte base which is similar to ECF
30
Warm Continuous Retrograde Blood Cardioplegia: Lichtenstein (1991) suggested that the heart could be maintained at
37ºC throughout the cross clamp period to enhance perioperative myocardial function
31
Warm Continuous Retrograde Blood Cardioplegia: “Warm Heart Trial” (1994): Studied nearly 2000 patients randomized to normothermic or hypothermic cardioplegia-- they found that...
Normothermic patients experienced a lower incidence | of post-operative low output syndrome with no differences in mortality or myocardial infarction
32
Warm retrograde cardioplegia flow must be
>100 mL/min to minimize myocardial lactate production
33
Cross clamp drugs right after cross clamp removal
lidocaine | mannitol
34
Single Clamp Technique=
One clamp episode One unclamp episode Distals and proximals done during one ischemic time
35
Single Clamp Technique is used with
Used with calcified stiff aortas
36
Side Biting Clamp Technique=
Two clamp episodes Two unclamping episodes Distals done during first ischemic time Proximals done during second ischemic time
37
Side Biting Clamp Technique has shorter
cross clamp times
38
Side Biting Clamp Technique= Ischemic time is
only with fully clamped aorta
39
Intermittent Crossclamp=
Increased risk of stroke | Not commonly used
40
Intermittent Crossclamp: clamp time is
the sum of all fully ischemic times
41
Fibrillatory Arrest=
Creates a nearly motionless heart by placing an alternating current generator in contact with the left ventricle
42
Fibrillatory Arrest: Left side of heart can be
opened without the fear of ejecting air into the aorta.
43
Fibrillatory Arrest: Should be used in conjunction with
hypothermia
44
Fibrillatory Arrest: Advantages
Avoid cross clamp | Quiescent heart with coronary perfusion
45
Fibrillatory Arrest: Disadvantages
Higher energy requirement than arrested heart | Spontaneous ejection will result in air emboli
46
Fibrillatory Arrest: Keep ____ elevated
MAP
47
Additional Strategies to Enhance Protection (7)
``` Anesthetic agents (↑ preconditioning) Acute normovolemic hemodilution (↓ A fib) Neutrophil depletion (↓ V fib) Erythropoietin (↓ myocardial injury) N-acetylcysteine (↓ oxidative stress) Deferoxamine (↓lipid peroxidation) Statins (↑NO release) ```
48
Anesthetic agents does what?
(↑ preconditioning)
49
Acute normovolemic hemodilution does what?
(↓ A fib)
50
Neutrophil depletion does what?
(↓ V fib)
51
Erythropoietin does what?
(↓ myocardial injury)
52
N-acetylcysteine does what?
(↓ oxidative stress)
53
Deferoxamine does what?
(↓lipid peroxidation)
54
Statins does what?
(↑NO release)
55
Monitoring Effectiveness for the Perfusionist | •GOAL:
``` optimize uniformity and effectiveness of delivery (especially retrograde) •Temperature •pH •Electrical Activity ```
56
Monitoring-Temperature: Thermo coupled needle usually inserted
septal muscle | myocardial temp probe
57
Monitoring-Temperature: Ensure delivery of
``` adequate dose (is it going where it belongs?) ```
58
Monitoring-Temperature: See efficacy of delivery •Antegrade- •Retrograde-
* Antegrade-cases of aortic insufficiency | * Retrograde-cannula position ( in RA?)
59
Monitoring-Temperature: Determine when
next dose needed | timers
60
What can the perfusionist do if arrest is not occurring as | expected?
is aortic valve competent/insufficient did it go the the LV change from antegrade to retrograde is the aortic clamp not on all the way (dilutes cardioplegia) low K instead of high K? bridge open or closed? hypertrophied LV walls require a higher pressure
61
Temperatures effect on pH and partial pressure assuming O2 content is constant: Increase temp=
``` Shift curve to the right Decrease HOH Increase H+ Increase OH- Decrease pH ```
62
Temperatures effect on pH and partial pressure assuming O2 content is constant: Decrease temp=
``` Shift curve to the left Increase HOH Decrease H+ Decrease OH- Increase pH ```
63
Failure to arrest can be due to
``` Aortic insufficiency Cross-clamp or cardioplegia needle malpositioned Inadequate solution (low potassium) Low flow? Low pressure? Temperature? ```
64
Myocardial Protection for Off-Pump Procedures: | Regional ischemia unavoidable- May become...
global problem when multiple vessels grafted
65
Myocardial Protection for Off-Pump Procedures: | Use of suction-based stabilizers has reduced the problem of
working on a moving target •Provide good exposure without excess compression of ventricle
66
Myocardial Protection for Off-Pump Procedures: | Ischemic preconditioning=
Brief period of vessel occlusion before occluding for | construction of the anastomosis
67
Myocardial Protection for Off-Pump Procedures: | Keep normal to high...
systemic blood pressure •May increase flow through collaterals vessels
68
Myocardial Protection for Off-Pump Procedures: | Attach proximal end of graft before
attaching distal | •Immediate re-establishment of flow to ischemic area
69
Myocardial Protection for Off-Pump Procedures: | Use of _______ shunt
intracoronary
70
Myocardial Protection for Off-Pump Procedures: | Perfusion-assisted...
direct coronary artery bypass (PADCAB) | •Perfuse completed grafts
71
Ingredients to know (7)
``` K+ Na+ Ca++ NaHCO3 THAM Glucose Mannitol ```
72
Actions of K+
electromechanical arrest
73
Actions of Na+
↓ edema/intracelluar Ca++ buildup
74
Actions of Ca++
Membrane stabilization
75
Actions of NaHCO3
↑ pH
76
Actions of THAM
↑ pH
77
Actions of Glucose
Substrate, ↑ Osmolarity, ↓ edema
78
Actions of Mannitol
↑ Osmolarity
79
Solution Concentrations: KCl High K Low K
High K= 100 mmol/L | Low K= 40 mmol/L
80
Solution Concentrations: THAM High K Low K
High K= 12 mmol/L | Low K= 12 mmol/L
81
Solution Concentrations: MgSO4 High K Low K
High K= 9 mmol/L | Low K= 9 mmol/L
82
Solution Concentrations: Dextrose High K Low K
High K= 250 mmol/L | Low K= 250 mmol/L
83
Solution Concentrations: CPD High K Low K
High K= 20 ml | Low K= 20 ml